Annual Report 2022
Report by the Board of Directors
Home   >  Report by the Board of Directors  >  Research and Development

Research and Development

Bittium continued to make significant investments to develop its own products and product platforms. In January–December 2022, the R&D investments were EUR 22.3 million (EUR 19.8 million), representing 27.0 percent of the net sales (22.8 percent).

The R&D investments focused mainly on developing medical technology products, developing tactical communication system and its products for the defense industry, and developing different types of special terminal products for authorities and their related security software.

The capitalized R&D investments are related to the investments in developing the software-defined radio-based tactical radios, Bittium Tough SRD™ product family, further development of tactical communication networks, and development of medical technology products.


R&D investments, MEUR  1-12/2022 1-12/2021
Total R&D investments 22.3 19.8
Capitalized R&D investments -6.6 -7.0
Depreciations and impairment of R&D investments 5.9 5.5
Cost impact on income statement 21.5 18.3
R&D investments, % of net sales 27.0% 22.8


Capitalized R&D investments in balance sheet, MEUR  1-12/2022 1-12/2021
Balance sheet value in the beginning of the period 48.1 46.6
Additions during the period 6.6 7.0
Depreciations and impairment of R&D investments -5.9 -5.5
Balance sheet value at the end of the period 48.8 48.1